LIPIODOL RETENTION AND MASSIVE NECROSIS AFTER LIPIODOL-CHEMOEMBOLIZATION OF HEPATOCELLULAR-CARCINOMA - CORRELATION BETWEEN COMPUTED-TOMOGRAPHY AND HISTOPATHOLOGY

被引:60
作者
IMAEDA, T
YAMAWAKI, Y
SEKI, M
GOTO, H
IINUMA, G
KANEMATSU, M
MOCHIZUKI, R
DOI, H
SAJI, S
SHIMOKAWA, K
机构
[1] Department of Radiology, Gifu University School of Medicine, Gifu City, 500
[2] Department of Second Surgery, Gifu University School of Medicine, Gifu City, 500
[3] Department of Laboratory Medicine, Gifu University School of Medicine, Gifu City, 500
关键词
LIPIODOL-CHEMOEMBOLIZATION; HEPATOCELLULAR CARCINOMA; LIPIODOL RETENTION; MASSIVE NECROSIS; CT;
D O I
10.1007/BF02602962
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This retrospective study examined the computed tomography (CT) criteria for judging the effectiveness of transcatheter arterial Lipiodol-chemoembolization (Lp-chemo-TAE) in 35 cases with hepatocellular carcinoma (HCC). Massive necrosis, defined as involving 97% or more of the HCC nodule, was observed in 15 cases after Lp-chemo-TAE, whereas nonmassive necrosis, defined as involving less-than-or-equal-to 96% of the HCC nodule, was observed in the remaining 20 cases. In 12 of 15 cases (80%) with massive necrosis, uniform dense retention of Lipiodol (Lp) was observed throughout the HCC nodule on CT images 3-4 weeks after Lp-chemo-TAE as opposed to only one (5%) of 20 cases with nonmassive necrosis (p < 0.01). Eight of nine cases (89%) with massive necrosis had tumor attentuation values of 365 Hounsfield units (HU) or greater on CT images 3-4 weeks after embolization, as opposed to only four (27%) of 15 cases with nonmassive necrosis (p < 0.01). We conclude that the effectiveness of the Lp-chemo-TAE can be judged on CT from the degree and duration of Lp retention in the HCC nodule and the measurement of the attenuation value of the HCC nodule.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 20 条
[1]  
Imaeda T., Yamawaki Y., Hirota K., Suzuki M., Goto H., Seki M., Asada S., Sone Y., Iinuma G., Doi H., Comparative studies on therapeutic effects of transcatheter arterial chemoembolization and intra-arterial one-shot infusion of anticancer drugs for unresectable hepatocellular carcinoma, Jpn J Clin Radiol, 32, pp. 807-813, (1987)
[2]  
Nakakuma K., Tashiro S., Uemura K., Konno T., Tanaka M., Yokoyama I., Studies on the anticancer treatment with oily anticancer drug injected into the ligated hepatic artery for liver cancer (preliminary report, in Japanese), Nichidoku Iho, 24, pp. 675-682, (1979)
[3]  
Idezuki Y., Sugiura M., Hatano S., Kimoto S., Hepatography for detection of small tumor masses in liver: Experiences with oily contrast medium, Surgery, 60, pp. 566-572, (1966)
[4]  
Nakakuma K., Tashiro S., Hiraoka T., Uemura K., Konno T., Miyauchi Y., Yokoyama I., Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer, Cancer, 52, pp. 2193-2200, (1983)
[5]  
Konno T., Maeda H., Iwai K., Tashiro S., Maki S., Morinaga T., Mochinaga M., Hiraoka T., Yokoyama I., Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: A preliminary report, Eur J Cancer Clin Oncol, 19, pp. 1053-1065, (1983)
[6]  
Jinno K., Moriwaka S., Tokuyama K., Yumoto Y., Fukuda K., Maeda H., Konno T., Clinico-pathologic study on selective accumulation of Lipiodol, an oily contrast medium, in hepatocellular carcinoma, Kanzo, 27, pp. 471-479, (1986)
[7]  
Iwai K., Maeda H., Konno T., Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image, Cancer Res, 44, pp. 2115-2121, (1984)
[8]  
Doppman J.L., Girton M., Kahn E.R., Proximal versus peripheral hepatic artery embolization: Experimental study in monkeys, Radiology, 128, pp. 577-588, (1978)
[9]  
Sakurai M., Okamura J., Kuroda C., Transcatheter chemoembolization effective for treating hepatocellular carcinoma: a histopathologic study, Cancer, 54, pp. 387-392, (1984)
[10]  
Satoh M., Yamada R., Experimental and clinical studies on the hepatic artery embolization for treatment of hepatoma, Nippon Act Radiol, 43, pp. 977-1005, (1983)